Financhill
Sell
37

LABU Quote, Financials, Valuation and Earnings

Last price:
$58.32
Seasonality move :
9.41%
Day range:
$56.37 - $59.46
52-week range:
$32.55 - $152.60
Dividend yield:
0.44%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.1M
Avg. volume:
2.4M
1-year change:
-47.32%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Direxion Daily S&P Biotech Bull 3X Shares has -- downside to fair value with a price target of -- per share.

LABU vs. S&P 500

  • Over the past 5 trading days, Direxion Daily S&P Biotech Bull 3X Shares has underperformed the S&P 500 by -2.37% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Direxion Daily S&P Biotech Bull 3X Shares does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Direxion Daily S&P Biotech Bull 3X Shares has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Direxion Daily S&P Biotech Bull 3X Shares reported revenues of --.

Earnings Growth

  • Direxion Daily S&P Biotech Bull 3X Shares has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Direxion Daily S&P Biotech Bull 3X Shares reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-17 2024-06-17 2024-06-17
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-06-17 2022-06-17 2023-06-17 2024-06-17
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-06-17 2024-06-17 2024-06-17
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
LABU
Sector
Market Cap
--
--
Price % of 52-Week High
38.51%
--
Dividend Yield
0.44%
--
Shareholder Yield
--
--
1-Year Price Total Return
-50.65%
--
Beta (5-Year)
2.551
--
Dividend yield:
0.44%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $59.83
200-day SMA
Sell
Level $92.86
Bollinger Bands (100)
Sell
Level 49.58 - 85.18
Chaikin Money Flow
Buy
Level 14.9M
20-day SMA
Buy
Level $55.52
Relative Strength Index (RSI14)
Buy
Level 54.71
ADX Line
Buy
Level 16.26
Williams %R
Neutral
Level -33.6272
50-day SMA
Buy
Level $52.16
MACD (12, 26)
Buy
Level 1.87
25-day Aroon Oscillator
Buy
Level 72
On Balance Volume
Neutral
Level 26.7M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, LABU has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LABU average analyst price target in the past 3 months is --.

  • Where Will Direxion Daily S&P Biotech Bull 3X Shares Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Direxion Daily S&P Biotech Bull 3X Shares share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Direxion Daily S&P Biotech Bull 3X Shares?

    Analysts are divided on their view about Direxion Daily S&P Biotech Bull 3X Shares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Direxion Daily S&P Biotech Bull 3X Shares is a Sell and believe this share price will rise from its current level to --.

  • What Is Direxion Daily S&P Biotech Bull 3X Shares's Price Target?

    The price target for Direxion Daily S&P Biotech Bull 3X Shares over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is LABU A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Direxion Daily S&P Biotech Bull 3X Shares is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of LABU?

    You can purchase shares of Direxion Daily S&P Biotech Bull 3X Shares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Direxion Daily S&P Biotech Bull 3X Shares shares.

  • What Is The Direxion Daily S&P Biotech Bull 3X Shares Share Price Today?

    Direxion Daily S&P Biotech Bull 3X Shares was last trading at $58.32 per share. This represents the most recent stock quote for Direxion Daily S&P Biotech Bull 3X Shares. Yesterday, Direxion Daily S&P Biotech Bull 3X Shares closed at $58.42 per share.

  • How To Buy Direxion Daily S&P Biotech Bull 3X Shares Stock Online?

    In order to purchase Direxion Daily S&P Biotech Bull 3X Shares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is down 89.92% over the past day.

Sell
16
VEON alert for Jun 17

VEON [VEON] is up 4.61% over the past day.

Buy
64
INOD alert for Jun 17

Innodata [INOD] is up 13.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock